NEW YORK (GenomeWeb) – Bruker reported after the close of the market Monday that its fourth quarter revenues declined 2 percent year over year.

For the three months ended Dec. 31, the company reported revenues of $470.3 million, down from $478.2 million in Q4 2015. The results beat the average analysts' estimate of $464.5 million.

Bruker said that the combined negative effects from currency translation and positive effects from acquisitions increased revenues in the recently completed quarter by less than 1 percent.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.